Register Interest for the 9th Neuroimmunology Drug Development Summit
Explore the Full Event Guide
- 50+ discovery, preclinical and translational neuroimmunology experts from leading biopharma and academia
- 3 days of cutting-edge insights across neuroinflammatory targets, glial biology, biomarkers and translational innovation
- Deep-dive agenda strand: Bridging Peripheral and Central Immunity, exploring next-generation B & T cell targets enabling earlier, more precise CNS intervention
- Hear from 25+ top speakers from Sanofi, Biogen, Merck, AbbVie, Bristol Myers Squibb, Lundbeck, Vigil Neuroscience and more
- Unmissable debates on humanized models, emerging insights into inflammation-driven psychosis mechanisms, and early clinical signals from novel neuroimmune-targeting therapies
